Firan Technology Group Corporation ("FTG") Announces Full Year and Fourth Quarter 2025 Financial Results

Firan Technology Group Corporation (TSX: FTG) (OTCQX: FTGFF) today announced financial results for the full year and the fourth quarter 2025. Full Year Financial ...

Praxis Precision Medicines, Inc.: Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

Two new drug applications (NDA) for ulixacaltamide in essential tremor (ET) and for relutrigine in SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs) have been submitted to the U.S.
Goldseiten

i-80 Gold Reports Fourth Quarter and Full Year 2025 Results; Continues to Advance Development Plan

Gold Corp. reports its operating and financial results, as well as development highlights, for the fourth quarter and full ...
Goldseiten

Artemis Gold Reports Q4 and Full Year 2025 Financial and Operating Results

ARTG Lowest decile AISC1 of US$869 per gold oz sold post-commercial production EBITDA1 of $237 million in Q4 2025 and $630 million in full year 2025 Operating cash flow of $198 million in Q4 2025 and ...